|
Index of reports
> Cases with Pancreatic Carcinoma ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Xolair (Omalizumab) where reactions include pancreatic carcinoma. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Xolair side effects in female
Reported by a physician from United States on 2012-01-11
Patient: female
Reactions: Pancreatic Carcinoma
Adverse event resulted in: death
Drug(s) suspected as cause:
Xolair
Indication: Asthma
Xolair
Dosage: 150 mg, 1/month, last dose: 22/aug/2011
Indication: Food Allergy
Start date: 2003-09-25
End date: 2011-08-01
Other drugs received by patient: Xopenex HFA
|
